Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ACCRUED EXPENSES (Details)

v3.22.2
SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,263,216 $ 5,435,464
Accrued product development costs 5,800 203,676
Accrued compensation 1,720,608 2,715,368
Accrued administrative costs 1,056,074 1,213,699
Accrued interest 670,724 525,105
Total $ 4,716,422 $ 10,093,312